New Penalties is a Push to Mitigate Cybersecurity Threats in Telecommunications and Healthcare

Amphenol banner ad

 

Cybersecurity has emerged as a critical issue in telecommunications and healthcare—two industries intertwined as essential services. With both sectors recognized as critical infrastructure, the consequences of cyber attacks can be far-reaching, impacting everything from individual privacy to national security. While recent regulatory changes are aiming to tighten security protocols, it also raises questions about the adequacy and effectiveness of current security practices.

How do the challenges and strategies in cybersecurity compare between telecommunications and healthcare? What impact do new regulations have on these critical industries?

Discussing the subject for an “Experts Talk” roundtable on cybersecurity in healthcare, Michael Isbitski, Director of Cybersecurity Strategy at Sysdig, provided some valuable insight into these pressing issues. Having nearly two decades of experience in telecommunications, Isbitski connected the parallels and divergences in cybersecurity challenges facing the two sectors. He further gave a comprehensive understanding of recent regulations and offered a clear picture of how the cybersecurity landscape is evolving.

Several takeaways from Isbitski’s discussion include:

  • The ways cyber attackers quickly evolve, posing continuous threats to critical infrastructure sectors such as telecommunications and healthcare.
  • Why the interconnected nature of modern industries means that compromising one can lead to cascading failures across others, highlighting the need for robust security in telecommunications as a backbone.
  • Recent cybersecurity regulations across various countries and sectors are aligning more closely with long-standing security practices, emphasizing better access control and intrusion monitoring.
  • The critical nature of cybersecurity and how it often competes with financial constraints within organizations, leading to potential vulnerabilities unless regulatory penalties enforce stricter compliance.
  • How so many organizations struggle with insufficient staffing and budget for cybersecurity, which can hinder their ability to effectively manage and mitigate risks.

Isbitski’s perspective shed some light on the importance of adopting and adapting to these new regulations to enhance the security and resilience of both telecommunications and healthcare industries. 

Article written by Alexandra Simon.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More